		Tuberculosis
		T-SPOT®.TB Overview
		Economic Impact
		Regulatory Information
		Frequently Asked Questions

		About Tuberculosis
		Diagnosing Tuberculosis
		Why Request T-SPOT®.TB?
		TB Vaccination and Treatment
		Frequently Asked Questions

Media Requests

The ability to identify individuals
who are truly infected with M. tuberculosis and who are at risk for disease will tremendously simplify the process of tuberculosis elimination in the United States.
- Institute of Medicine

Geiter L, "Ending Neglect: The elimination of Tuberculosis in the United States", 1^st ed., Washington DC: National Academy Press 2000.

Regulatory Information

The Food and Drug Administration (FDA) approved the PMA for the T-SPOT^®.TB test on July 30, 2008. T-SPOT.TB is the only blood test that has demonstrated in a pivotal clinical study both sensitivity and specificity exceeding ninety-five percent and reliability in all targeted groups.

The T-SPOT.TB test is CE marked in Europe and licensed in Canada.

For more information click here.

Get Email Updates